Delivery Order SPE2DB24D2011-SPE2DB26FBPAW
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of Eliquis 5 mg tablets (60-count units) with a ceiling value of $20,323.56. This is a firm fixed price delivery order with an ultimate completion date of October 17, 2025, and represents a non-competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Eliquis 5 mg tablets (60-count units) with a ceiling value of $25,763.39. This is a firm fixed price delivery order with an ultimate completion date of July 25, 2025, and represents a competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania, the company's corporate headquarters....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Eliquis 5 mg tablets (60-count) with a ceiling value of $2,060.28. This non-competitive, firm fixed-price delivery order is scheduled for completion by October 24, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical supply transaction under AmerisourceBergen's broader federal contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) with a ceiling value of $27,084.93. This is a firm fixed price delivery order with an ultimate completion date of September 4, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Eliquis 5 mg tablets (60-count units) valued at $4,119.68. This competitively awarded, non-set-aside contract carries a firm fixed price structure with an ultimate completion date of October 20, 2025. The order will be fulfilled from AmerisourceBergen's corporate office operations based in Conshohocken, Pennsylvania, where the company maintains its primary distribution...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 10, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) with a ceiling value of $27,309.78. This firm fixed-price delivery order is scheduled for completion by July 11, 2025, and will be fulfilled from the contractor's location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Eliquis 5 mg tablets (60-count units) with a firm fixed price ceiling value of $3,418.47. This is a non-set-aside competitive award with an ultimate completion date of August 28, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 17, 2025, for the supply of Eliquis 5 mg tablets (60-count units) with a ceiling value of $15,720.75. This firm fixed-price delivery order, with an ultimate completion date of June 18, 2025, represents a competitive award with no set-aside designation. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, supporting the agency's pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Eliquis 5 mg tablets (60-count units) with a ceiling value of $4,337.03. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is set to be completed by October 30, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Eliquis 5 mg tablets in a quantity of 60 units, with a ceiling value of $40,426.04. This is a firm fixed price delivery order with no set-aside designation, competitively awarded through open competition. The order is scheduled for completion by September 25, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken,...
- SPE2DB24D2011Indefinite Delivery Contract
- SPE2DB24D2011-SPE2DB26FBPAWDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Eliquis 5 mg tablets in a 60-count package, with a contract ceiling value of $16,108.92. This competitively awarded, firm fixed-price delivery order is scheduled for completion by November 3, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The contract carries no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to compete successfully in the open federal procurement marketplace. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 prime vendor agreement running through December 2026 that provides comprehensive global pharmaceutical support to military healthcare systems. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies an extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.1k | 10/31/25 |